Parkinson’s Disease

Parkinson’s Foundation Announces Major Expansion of PD GENEration Study, Increasing Access to Genetic Testing and Counseling Across the U.S.

CNS Disorders, Gene Testing, Genetic Testing, Genomic Tests, Neurodegenerative Disorders, Parkinson's, Parkinson's Disease, Parkinson's Disease, Parkinson's Disease, Parkinson’s disease, Parkinson’s disease, Parkinson’s disease, Parkinson’s Disease, Personalization, Personalized Care, Personalized health, Personalized Medicine, Personalized Therapeutics

The Parkinson’s Foundation has announced the expansion of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative offering genetic testing and counseling for people with Parkinson’s disease (PD) at no cost.

Neurocrine Terminates Parkinson’s Deal with Voyager Following Clinical Hold

Parkinson’s Disease

Shares of Voyager Therapeutics dropped more than 12 percent as investors reacted negatively to an announcement that Neurocrine Biosciences is terminating a Parkinson’s disease collaboration between the two companies.

Neurocrine, Voyager team up on PD gene therapy

Business, CNS, Friedreich's Ataxia (FA), Gene Therapy, Milestone Payments, Parkinson’s Disease, Partnerships

Shares of Voyager Therapeutics skyrocketed after the company announced a collaborative deal to develop a gene therapy treatment for Parkinson’s disease with Neurocrine Biosciences.